Literature DB >> 25271193

Diabetes mellitus as a risk factor for functional and cognitive decline in very old people: the Octabaix study.

Francesc Formiga1, Assumpta Ferrer2, Glòria Padrós3, Xavier Corbella4, Lourdes Cos5, Alan J Sinclair6, Leocadio Rodríguez-Mañas7.   

Abstract

OBJECTIVES: To examine the incidence of functional or cognitive impairment and its associated factors in a sample of individuals aged 85 years or older with and without diabetes mellitus, who were free of significant impairment at baseline.
DESIGN: Longitudinal study.
SETTING: Community-based survey study of 7 primary health care centers. PARTICIPANTS: A total of 167 individuals born in 1924 who completed 2 years of follow-up. MEASUREMENTS: Sociodemographic variables, the Barthel Index (BI), the Spanish version of Mini-Mental State Examination (MEC), the Mini Nutritional Assessment (MNA), the Charlson Comorbidity Index, and a list of chronic drug prescriptions. A comparative analysis was performed between diabetic and nondiabetic patients regarding the rate of functional and cognitive impairment. In addition, in older people with diabetes experiencing incident disability, an analysis of the potential factors involved was carried out.
RESULTS: The prevalence of diabetes (DM) at baseline in this population was 25.1%. After 2 years of follow-up, 66.8% of patients with DM had developed a new impairment measured as 38.1% for the defined target of loss of BI of 10 or more and 33.3% for the cognitive target (MEC scores lower than 24 or loss >4 points in MEC). In a multivariate analysis, diabetic patients had an increased risk of any new disability (OR 2.05, 95% CI 1.01-4.36; P = .04). Logistic regression showed an association between any new disability and baseline scores of MNA (OR 1.35, 95% CI 1.01-1.82; P = .04) and MEC (OR 1.38, 95% CI 1.02-1.85; P = .003).
CONCLUSION: This study has identified that in the oldest old, community-dwelling individuals without evidence of severe functional impairment at baseline, diabetes increases the risk of incident disability in only 2 years.
Copyright © 2014 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; cognitive status; disability; functional status; geriatric assessment; oldest old

Mesh:

Year:  2014        PMID: 25271193     DOI: 10.1016/j.jamda.2014.07.019

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  4 in total

1.  Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data.

Authors:  Mary Sano; Carolyn W Zhu; Hillel Grossman; Corbett Schimming
Journal:  J Am Geriatr Soc       Date:  2017-08-03       Impact factor: 5.562

2.  Type 2 Diabetes Mellitus Is Associated with the Risk of Cognitive Impairment: a Meta-Analysis.

Authors:  Xiaojun Zhang; Xiaolu Jiang; Sufang Han; Qianqi Liu; Jing Zhou
Journal:  J Mol Neurosci       Date:  2019-04-04       Impact factor: 3.444

3.  High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction.

Authors:  Jing Wu; Shan-Lei Zhou; Lin-Hua Pi; Xia-Jie Shi; Ling-Ran Ma; Zi Chen; Min-Li Qu; Xin Li; Sheng-Dan Nie; Duan-Fang Liao; Jin-Jing Pei; Shan Wang
Journal:  Oncotarget       Date:  2017-06-20

4.  Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study.

Authors:  Nienke Legdeur; Maryam Badissi; Stephen F Carter; Sophie de Crom; Aleid van de Kreeke; Ralph Vreeswijk; Marijke C Trappenburg; Mardien L Oudega; Huiberdina L Koek; Jos P van Campen; Carolina J P W Keijsers; Chinenye Amadi; Rainer Hinz; Mark F Gordon; Gerald Novak; Jana Podhorna; Erik Serné; Frank Verbraak; Maqsood Yaqub; Arjan Hillebrand; Alessandra Griffa; Neil Pendleton; Sophia E Kramer; Charlotte E Teunissen; Adriaan Lammertsma; Frederik Barkhof; Bart N M van Berckel; Philip Scheltens; Majon Muller; Andrea B Maier; Karl Herholz; Pieter Jelle Visser
Journal:  BMC Geriatr       Date:  2018-11-26       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.